Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences
Breadcrumb Trail Links GlobeNewswire Author of the article: Published May 22, 2024 • Last updated 4 minutes ago • 10 minute read Article content Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a …